Rights and permissions
About this article
Cite this article
Sulconazole: the topical antifungal [Syntex] has been approved to enter its first market in Switzerland (continued). Inpharma Wkly. 483, 19 (1985). https://doi.org/10.1007/BF03305378
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03305378